Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease

被引:104
作者
Kimbrough, Ian F. [1 ,2 ]
Robel, Stefanie [1 ,2 ]
Roberson, Erik D. [1 ,3 ,4 ]
Sontheimer, Harald [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Ctr Glial Biol Med, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL USA
关键词
Alzheimer's disease; vascular amyloid; amyloidosis; neurovascular coupling; multi-photon imaging; BLOOD-BRAIN-BARRIER; AQUAPORIN EXPRESSION; TRANSGENIC MICE; ANGIOPATHY; CALCIUM; PROGRESSION; PATHOLOGY; AGRIN; CA2+; MICROVASCULATURE;
D O I
10.1093/brain/awv327
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Reduced cerebral blood flow impairs cognitive function and ultimately causes irreparable damage to brain tissue. The gliovascular unit, composed of neural and vascular cells, assures sufficient blood supply to active brain regions. Astrocytes, vascular smooth muscle cells, and pericytes are important players within the gliovascular unit modulating vessel diameters. While the importance of the gliovascular unit and the signals involved in regulating local blood flow to match neuronal activity is now well recognized, surprisingly little is known about this interface in disease. Alzheimer's disease is associated with reduced cerebral blood flow. Here, we studied how the gliovascular unit is affected in a mouse model of Alzheimer's disease, using a combination of ex vivo and in vivo imaging approaches. We specifically labelled vascular amyloid in living mice using the dye methoxy-XO4. We elicited vessel responses ex vivo using either pharmacological stimuli or cell-specific calcium uncaging in vascular smooth muscle cells or astrocytes. Multi-photon in vivo imaging through a cranial window allowed us to complement our ex vivo data in the presence of blood flow after label-free optical activation of vascular smooth muscle cells in the intact brain. We found that vascular amyloid deposits separated astrocyte end-feet from the endothelial vessel wall. High-resolution 3D images demonstrated that vascular amyloid developed in ring-like structures around the vessel circumference, essentially forming a rigid cast. Where vascular amyloid was present, stimulation of astrocytes or vascular smooth muscle cells via ex vivo Ca2+ uncaging or in vivo optical activation produced only poor vascular responses. Strikingly, vessel segments that were unaffected by vascular amyloid responded to the same extent as vessels from age-matched control animals. We conclude that while astrocytes can still release vasoactive substances, vascular amyloid deposits render blood vessels rigid and reduce the dynamic range of affected vessel segments. These results demonstrate a mechanism that could account in part for the reduction in cerebral blood flow in patients with Alzheimer's disease.
引用
收藏
页码:3716 / 3733
页数:18
相关论文
共 69 条
[1]
Glial and neuronal control of brain blood flow [J].
Attwell, David ;
Buchan, Alastair M. ;
Charpak, Serge ;
Lauritzen, Martin ;
MacVicar, Brian A. ;
Newman, Eric A. .
NATURE, 2010, 468 (7321) :232-243
[2]
Tone-dependent vascular responses to astrocyte-derived signals [J].
Blanco, Victor M. ;
Stern, Javier. E. ;
Filosa, Jessica A. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (06) :H2855-H2863
[3]
Patterns of brain activation in people at risk for Alzheimer's disease [J].
Bookheimer, SY ;
Strojwas, MH ;
Cohen, MS ;
Saunders, AM ;
Pericak-Vance, MA ;
Mazziotta, JC ;
Small, GW .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07) :450-456
[4]
Assembly of a perivascular astrocyte protein scaffold at the mammalian blood-brain barrier is dependent on α-syntrophin [J].
Bragg, AD ;
Amiry-Moghaddam, M ;
Ottersen, OP ;
Adams, ME ;
Froehner, SC .
GLIA, 2006, 53 (08) :879-890
[5]
Label-free optical control of arterial contraction [J].
Choi, Myunghwan ;
Yoon, Jonghee ;
Choi, Chulhee .
JOURNAL OF BIOMEDICAL OPTICS, 2010, 15 (01)
[6]
The vasoactivity of A beta peptides [J].
Crawford, F ;
Suo, ZM ;
Fang, CH ;
Sawar, A ;
Su, G ;
Arendash, G ;
Mullan, M .
CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE, 1997, 826 :35-46
[7]
Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease [J].
Domnitz, SB ;
Robbins, EM ;
Hoang, AW ;
Garcia-Alloza, M ;
Hyman, BT ;
Rebeck, GW ;
Greenberg, SM ;
Bacskai, BJ ;
Frosch, MP .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (07) :588-594
[8]
DORN GW, 1993, J PHARMACOL EXP THER, V265, P447
[9]
Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease [J].
Dorr, Adrienne ;
Sahota, Bhupinder ;
Chinta, Lakshminarayan V. ;
Brown, Mary E. ;
Lai, Aaron Y. ;
Ma, Keran ;
Hawkes, Cheryl A. ;
McLaurin, JoAnne ;
Stefanovic, Bojana .
BRAIN, 2012, 135 :3039-3050
[10]
RESPONSE OF ISOLATED INTRACEREBRAL ARTERIOLES TO ENDOTHELINS [J].
EDWARDS, R ;
TRIZNA, W .
PHARMACOLOGY, 1990, 41 (03) :149-152